EUCR
Eucrates Biomedical Acquisition
EUCR | NASDAQ
Chart Builder DCF Calculator
$10.04
$0.00 (0.00%)
At close: Apr 26, 2023, 03:14 PM ET

Eucrates Biomedical Acquisition Cash Flow Statement

Cash flow statement explained
Fiscal Year
Period Ending
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
2.42M 3.82M
– –
– –
– –
-3.12M -4.57M
– –
68.29K 240.96K
-630.29K -502.11K
– –
– –
– –
– –
93.19M –
93.19M –
– –
-93.19M –
– –
-92.59M –
-92.59M –
-30.29K -502.11K
-630.29K -502.11K
-630.29K -502.11K
– –
– –
-630.29K -502.11K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.